about
Activation of Src and transformation by an RPTPα splice mutant found in human tumoursFilopodia and Viruses: An Analysis of Membrane Processes in Entry MechanismsSignaling Pathways in Thyroid Cancer and Their Therapeutic ImplicationsThe molecular effect of metastasis suppressors on Src signaling and tumorigenesis: new therapeutic targetsGrowth factor and signaling pathways and their relevance to prostate cancer therapeuticsProtein-intrinsic and signaling network-based sources of resistance to EGFR- and ErbB family-targeted therapies in head and neck cancerThe mechanistic basis of arsenicosis: pathogenesis of skin cancerThe molecular rationale of Src inhibition in colorectal carcinomasAndrogen receptor activation in castration-recurrent prostate cancer: the role of Src-family and Ack1 tyrosine kinasesResistance and escape from antiangiogenesis therapy: clinical implications and future strategiesThe interaction between caveolin-1 and Rho-GTPases promotes metastasis by controlling the expression of alpha5-integrin and the activation of Src, Ras and ErkIn silico investigation of potential SRC kinase ligands from traditional Chinese medicineA comprehensive, multi-scale dynamical model of ErbB receptor signal transduction in human mammary epithelial cellsDistinct effects of the mesenchymal dysplasia gene variant of murine Patched-1 protein on canonical and non-canonical Hedgehog signaling pathwaysAugmentation of the anticancer activity of CYT997 in human prostate cancer by inhibiting Src activity.Promotion of Tumor Invasion by Tumor-Associated Macrophages: The Role of CSF-1-Activated Phosphatidylinositol 3 Kinase and Src Family Kinase Motility Signaling.PRL-3 engages the focal adhesion pathway in triple-negative breast cancer cells to alter actin structure and substrate adhesion properties critical for cell migration and invasionThe Src family kinase inhibitor dasatinib delays pain-related behaviour and conserves bone in a rat model of cancer-induced bone pain.Posttranscriptional deregulation of Src due to aberrant miR34a and miR203 contributes to gastric cancer developmentCombined blockade of Src kinase and epidermal growth factor receptor with gemcitabine overcomes STAT3-mediated resistance of inhibition of pancreatic tumor growthShikonin induces apoptosis and inhibits migration of ovarian carcinoma cells by inhibiting the phosphorylation of Src and FAK.A novel piperazine derivative potently induces caspase-dependent apoptosis of cancer cells via inhibition of multiple cancer signaling pathways1'-Acetoxychavicol acetate suppresses angiogenesis-mediated human prostate tumor growth by targeting VEGF-mediated Src-FAK-Rho GTPase-signaling pathway.Proteomics: a strategy to understand the novel targets in protein misfolding and cancer therapy.Dissecting the cell to nucleus, perinucleus and cytosol.Src family kinases and paclitaxel sensitivity.miR-203 suppresses the proliferation and migration and promotes the apoptosis of lung cancer cells by targeting SRC.Adenovirus-mediated delivery of bFGF small interfering RNA reduces STAT3 phosphorylation and induces the depolarization of mitochondria and apoptosis in glioma cells U251.Cellular settings mediating Src Substrate switching between focal adhesion kinase tyrosine 861 and CUB-domain-containing protein 1 (CDCP1) tyrosine 734Plakophilin-2 induced EGFR phosphorylation: a focus on the intracellular activators of EGFRIdentification of a Src tyrosine kinase/SIAH2 E3 ubiquitin ligase pathway that regulates C/EBPδ expression and contributes to transformation of breast tumor cells.Activation of the aryl hydrocarbon receptor by the widely used Src family kinase inhibitor 4-amino-5-(4-chlorophenyl)-7-(dimethylethyl)pyrazolo[3,4-d]pyrimidine (PP2).Advances in small-molecule drug discovery for triple-negative breast cancer.The use of single-agent dasatinib in molecularly unselected non-small-cell lung cancer patientsThe proto-oncogene c-Src and its downstream signaling pathways are inhibited by the metastasis suppressor, NDRG1.Retinoic acid reduces migration of human breast cancer cells: role of retinoic acid receptor betaThe Notch-mediated hyperplasia circuitry in Drosophila reveals a Src-JNK signaling axis.Early Candidate Biomarkers of Non-Small Cell Lung Cancer Are Screened and Identified in Premalignant Lung Lesions.Dasatinib enhances antitumor activity of paclitaxel in ovarian cancer through Src signaling.Cyr61 as mediator of Src signaling in triple negative breast cancer cells.
P2860
Q24310234-22401C2A-56EC-467E-A614-39DF97967B64Q26751070-14C72C99-9662-450E-848D-09A72B09B5F8Q26764899-9138F92F-B07F-4CBF-B1F6-50934E445CC3Q26782593-703E820E-F360-41DF-B0AC-3624400C00FAQ26827975-C06AFDDC-36AB-4421-859E-872CADA4064BQ26852215-1C961EE3-9D96-453B-A2B4-6E69B65EFAE9Q26852764-D8145D72-BDE7-4BAC-AE2A-B6B5E32AB6B2Q26853018-57D321E2-50A2-4560-B73F-99EAE0866078Q26866135-844E7478-4117-42E7-A2C3-93D33C578A04Q27016629-ECFA59B7-F2FA-422C-9792-03DA5D00320CQ28243414-F2FDB287-D71F-427D-A8ED-F08F06CC7D19Q28481644-E6C58218-DB12-4178-B202-D2DB4609BFD1Q28486292-AEFC3D76-8A72-4A5F-9F37-E3A63197AA93Q30009457-1BC5EE44-8678-459B-BAEB-DA1428785128Q33792131-70334B4D-5114-4A9E-A956-4B4738E134A5Q33832775-59FDF1C4-C7A1-4491-B409-39816DEA5FEDQ33872677-0E4E78D7-2616-4DA0-887C-B73C126AE6B2Q33881060-C80DCD88-5252-470A-A430-50B246A87D80Q34049494-C9F22088-B4E8-4B47-AD27-6645C50FC63BQ34812100-6263C7AD-CFFD-4F1E-B39B-57F91BCF271BQ34993806-F395DF88-4F41-49C1-8FE5-D8AF9324637CQ35007768-2986EBB0-72C1-4E00-A58B-77C122CBEC0EQ35020469-03109123-DE59-4459-88A9-012A6A76C478Q35116243-D6DDB9CA-3F46-4605-8E6D-73BE79540308Q35166355-CF0106A5-7DEE-484B-9141-F4B59AC4DC51Q35214722-C263FB0A-30DB-47BE-884B-195396FECBE8Q35228579-FB09BFB7-087A-471E-A739-3E3F00042095Q35230410-8212AB25-0C70-48F0-AC55-3ED6ACC6A952Q35605121-8CAA4005-FF21-4BE9-97D6-13A7E7584A55Q35618896-B290E530-788E-4242-8913-9EA48A463AE1Q35665700-19E06AE4-DAE8-473E-B24A-FF6B1676B4EFQ35680450-3479EC59-88DB-407C-91F1-AD891154AE3AQ35818491-A4DC7328-7CAC-4C62-A9E3-55BB184434D2Q35829847-878D5B90-37A7-47F3-9658-21D32AA3983FQ35832242-F9C25E84-C06B-42E6-8764-C88E3994BBF3Q35867945-57ACE7CD-16F6-4DA2-86CC-4D6C4D2F7F05Q35896180-B9EA3A95-3A72-4B12-BF5B-FA87B6F1DB74Q35904126-0676AC7B-EAFC-4B88-9DA5-F384448AADF7Q35919774-5BBC26E7-41A6-4625-89B8-6CAD42C5940EQ35955373-BBCBE0C2-E90F-44A6-AAC9-5F94ECC8BA9A
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
The role of Src in solid tumors
@ast
The role of Src in solid tumors
@en
The role of Src in solid tumors
@nl
type
label
The role of Src in solid tumors
@ast
The role of Src in solid tumors
@en
The role of Src in solid tumors
@nl
prefLabel
The role of Src in solid tumors
@ast
The role of Src in solid tumors
@en
The role of Src in solid tumors
@nl
P2093
P2860
P3181
P1433
P1476
The role of Src in solid tumors
@en
P2093
Deric L Wheeler
Emily F Dunn
P2860
P304
P3181
P356
10.1634/THEONCOLOGIST.2009-0009
P407
P577
2009-07-01T00:00:00Z